Modified protocol of omalizumab treatment to prevent carboplatin-induced drug hypersensitivity reactions: a case studyOude Elberink, H. N. G., Jalving, M., Dijkstra, H. & van de Ven, A. A. J. M., 29-Jan-2020, In : Clinical and translational allergy. 10, 1, 5 p., 5.
Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review
Carboplatin administration can usually be safely continued via a so-called desensitisation protocol when hypersensitivity reactions arise. Severe break-through reactions that occur early during desensitisation are likely to be IgE-mediated; in that case, addition of omalizumab premedication should be strongly considered.
- Carboplatin, Desensitisation, Drug hypersensitivity, Omalizumab, DESENSITIZATION, OXALIPLATIN